Top Biotechnology & Medical Research stocks in North America
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
VRTXVertex Pharmaceuticals | $109.10bn | 27.43 | n/a |
REGNRegeneron Pharmaceuticals | $107.30bn | 27.77 | n/a |
MRNAModerna | $44.96bn | n/a | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
IQVIqvia Holdings | $42.65bn | 30.39 | n/a |
ICLRIcon | $26.08bn | 34.87 | n/a |
BNTXBioNTech SE | $21.79bn | 169.57 | n/a |
ALNYAlnylam Pharmaceuticals | $19.03bn | n/a | n/a |
NBIXNeurocrine Biosciences | $13.76bn | 37.18 | n/a |
TECHBIO-TECHNE | $12.75bn | 60.24 | 0.4% |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
SRPTSarepta Therapeutics | $12.46bn | n/a | n/a |
MEDPMedpace Holdings | $12.09bn | 39.76 | n/a |
CRLCharles River Laboratories International | $11.75bn | 24.43 | n/a |
UTHRUnited Therapeutics | $11.72bn | 12.47 | n/a |
EXASExact Sciences | $9.87bn | n/a | n/a |
QGENQiagen NV | $9.67bn | 26.18 | n/a |
RXDXPrometheus Biosciences | $9.56bn | n/a | n/a |
IMGNImmunoGen | $8.72bn | n/a | n/a |
VKTXViking Therapeutics | $8.12bn | n/a | n/a |